US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of two arms. This study is direct to participant and will not utilize clinical sites.
Participants who meet the eligibility criteria are randomized into any of the two arms including: the placebo arm or the VIOME Precision Nutrition Program (VPNP) arm. Placebo and Viome's Precision Nutrition Program include supplements and/or dietary recommendations towards improving the symptoms associated with metabolic wellness. The trial will last approximately 4 months for each participant.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
Precision supplement based on the participants microbiome sample results. Participants in this arm may have any combination of supplements, diet recommendations, and/or coaching.
Participants who have mental health issues are randomized into this arm. They may be provided with any combination of nutritional recommendations and/or supplements. Placebo capsules will contain inert and inactive materials. Participants may need to use a mobile app in order to participate in the trial.
Viome Life Sciences
Bothell, Washington, United States
RECRUITINGChange in PHQ-9 Score
Change in PHQ-9 score for VPNP group compared to baseline scores.
Time frame: 4 months
Change in GAD-7 Score
Change in GAD-7 score for VPNP group compared to baseline scores.
Time frame: 4 months
Change in Quality of Life Score
Change in quality of life score for VPNP group compared to baseline scores.
Time frame: 4 months
Change in Perceived Stress Scale Score
Change in perceived stress score for VPNP group compared to baseline scores.
Time frame: 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.